LAS VEGAS, July 16, 2014 /PRNewswire/ -- GrowBLOX
Sciences, Inc. (OTCQB: GBLX) a medical marijuana research and
development company, is pleased to announce it has entered the
Florida Medical Marijuana Market through its new subsidiary, GB
Sciences Florida, LLC. With nearly 20 million residents,
Florida is poised to be the
biggest medical marijuana market outside of California. The National Cannabis Industry
Association estimates medical marijuana will be a $785 million industry in Florida with multiple economic opportunities.
In November, Florida voters will
decide if they should allow widespread sale and use of medical
cannabis by saying "yay" or "nay"
on The Florida Right to Medical Marijuana
Initiative, commonly known as Amendment 2. Early polls show
that voters are likely to approve the ballot as all expectations
are for a landslide approval. If and when Florida approves the bill, it will become the
first state in the Southeast to do so.
Furthermore, GrowBLOX Sciences recognizes Florida's high standards for quality in
medical marijuana cultivation as a perfect match for their
GrowBLOX™ cultivation technology. GrowBLOX CEO, Craig Ellins, said, "In an effort to safeguard
Florida's medical marijuana
patients, Florida's legislators
have crafted some of the country's most stringent quality standards
when it comes to the safety and efficacy of the medical marijuana
grown in their state. They want medical solutions, and that's
exactly what our GrowBLOX™ does, it makes medicine."
The GrowBLOX™ cultivation chamber is uniquely designed to
produce medical marijuana with consistent potency from harvest to
harvest. Medical marijuana grown in our GrowBLOX™ is also
completely shielded from harmful pesticides, insecticides, and
other pollutants. This provides medical marijuana patients with
peace of mind knowing that they are receiving the same quality and
quantity of active compounds within our medicinal marijuana with
each use. Mr. Ellins made this comparison, "Think of when you buy a
bottle of over the counter medication. Whether you buy that
medication in New York or
Texas, you know that you are
getting the exact same medication no matter where or when you buy
it. That is the idea behind the GrowBLOX™ cultivation system.
Plants grown through other grow conditions will have harvest to
harvest inconsistencies. We want our customers to know that they
are getting the same medicine each and every time."
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and development company
that has proprietary indoor growing chambers specifically designed
for medical cannabis cultivation. The GrowBLOX™ chamber allows for
completely controlled growing conditions, ensuring the manufacture
of a consistent, toxin-free, natural and medicinal-grade product.
The Company believes that the advantages of a controlled
environment over traditional outdoor or greenhouse growing, will
empower the public, nutraceutical and pharmaceutical industries to
embrace cannabis as an effective treatment for a myriad of serious
medical conditions. http://www.gbsciences.com
Forward-Looking Statements
Except for historical information contained herein, the
statements in this release are forward-looking and made pursuant to
the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements are inherently
unreliable and actual results may differ materially. Examples
of forward-looking statements in this news release include
statements regarding the payment of dividends, marketing and
distribution plans, development activities and anticipated
operating results. Factors which could cause actual results to
differ materially from these forward-looking statements include
such factors as the Company's ability to accomplish its business
initiatives, significant fluctuations in marketing expenses and
ability to achieve and expand significant levels of revenues, or
recognize net income, from the sale of its products and services,
as well as the introduction of competing products, or management's
ability to attract and maintain qualified personnel necessary for
the development and commercialization of its planned products, and
other information that may be detailed from time to time in the
Company's filings with the United States Securities and Exchange
Commission. The Company undertakes no obligation to publicly update
or revise any forward-looking statements, whether as a result of
new information, future events or otherwise.
Contact:
Jonathan Barkman
Riverview Capital Enterprises
+1-866-845-0105
SOURCE GrowBLOX Sciences, Inc.